Clinical Trials Logo
  1. Home
  2. Respiration Disorders
  3. NCT03819023
  4. Details
NCT03819023 Clinical Trial

Validation of RespiLife for Detection of Respiratory Suppression

Respiration Disorders Clinical Trial

Official title:
Validation of RespiLife for Detection of Respiratory Suppression

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03819023
Other study ID # BR01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 20, 2018
Est. completion date March 20, 2019

Study information
Verified date April 2019
Source Bioresp Technologies, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

Description:

The purpose of this study is to evaluate the accuracy of RespiLife diagnostic technology for detection of respiratory rate and oxygen saturation in human subjects. This includes evaluation of Bioresp's RespiLife and its accuracy for measurement of respiratory rate and oxygen saturation.

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date March 20, 2019
Est. primary completion date March 2, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Able to understand and sign the informed consent

- English speaking.

- Able to comply with visits and follow ups included in this protocol

- Ages 18-80 years

Exclusion Criteria:

- Mentally or cognitively incompetent persons who cannot understand the procedures or consent to the procedures.

- An unstable medical condition, acute of chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.

- If a subject is not able to stop his CPAP or BiPAP therapy at least one week prior to the sleep study night. This will be determined ty the principal investigator based on her judgment.

- Skin rash on the forehead.

- A history of skin allergy to medical tape, even hypoallergenic tape.

- A history of skin cancer on the forehead.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Respilife monitor
Respilife monitor

Locations
Country Name City State
United States Peninsula Sleep Center Burlingame California

Sponsors (1)
Lead Sponsor Collaborator
Bioresp Technologies, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary oxygen saturation percentage using photoplethysmography The Respilife algorithm will calculate the respiratory rate and oxygen saturation. The measurements will be compared and analyzed against the gold standard measurements using FDA -approved clinical tools, such as Nellcor oximeter and photoplethysmographer. 6 hours
Primary Respiratory rate, breaths per minute using photoplethysmography The Respilife algorithm will calculate the respiratory rate and oxygen saturation. The measurements will be compared and analyzed against the gold standard measurements using FDA -approved clinical tools, such as Nellcor oximeter and photoplethysmographer and piezo electric and respiratory inductance plethysmography. 6 hours
See also
  Status Clinical Trial Phase
Recruiting NCT03368612 - Comparative Study Between the AirGoTM System and Standard Tests in the Assessment of the Respiratory Function N/A
Recruiting NCT00530491 - Prospective Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With Reduced Pulmonary Capacity N/A
Completed NCT05267067 - Impact of Positive End Maximum Voluntary Ventilation and Dyspnea Index in Patients After Valvular Heart Surgery N/A
Active, not recruiting NCT04170348 - Daily Vitamin D for Sickle-cell Respiratory Complications Phase 2
Recruiting NCT06019949 - Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury N/A
Completed NCT05098808 - Artificial Intelligence in Diagnosing Dysphagia Patients
Enrolling by invitation NCT01727518 - The Austrian LEAD (Lung hEart sociAl boDy) Study N/A
Recruiting NCT03709199 - Long Term Follow up of Children Enrolled in the REDvent Study
Completed NCT01532180 - Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA) N/A
Terminated NCT00464490 - Use of Dexmedetomidine to Facilitate Extubation in Surgical ICU Patients Who Failed Previous Weaning Attempts N/A
Completed NCT00750074 - Slope of the Pressure-Time Waveform Predicts Resistance and Compliance in Mechanically Ventilated Subjects N/A
Completed NCT00202319 - Effectiveness of Sedation Management in an Australian Intensive Care Unit N/A
Completed NCT05270538 - Cardiorespiratory and Acid-basic Imbalance Caused by Use of Mask N/A
Terminated NCT02022072 - Evaluation of Vital Capacity Phase 2
Recruiting NCT05398068 - Effects of Exercise Training on Exercise Capacity and Sleep Quality in Patients With Obesity Hypoventilation Syndrome N/A
Completed NCT03327610 - Selecting the Best Ventilator Hyperinflation Settings N/A
Completed NCT00665405 - Atelectasis During Delivery - Comparing Cesarian (c) -Section and Labor N/A
Completed NCT00004424 - Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy N/A
Completed NCT04647383 - A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 1
Completed NCT01565954 - Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children